tiprankstipranks
Acadia Pharmaceuticals sees FY24 revenue $940M-$960M, consensus $952.5M
PremiumThe FlyAcadia Pharmaceuticals sees FY24 revenue $940M-$960M, consensus $952.5M
12d ago
Acadia Pharma sells Rare Pediatric Disease Priority Review Voucher for $150M
Premium
The Fly
Acadia Pharma sells Rare Pediatric Disease Priority Review Voucher for $150M
13d ago
ACAD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ACAD Upcoming Earnings Report: What to Expect?
14d ago
ACADIA Pharmaceuticals Welcomes New CEO, Unveils Compensation Plan
PremiumCompany AnnouncementsACADIA Pharmaceuticals Welcomes New CEO, Unveils Compensation Plan
2M ago
Acadia Pharmaceuticals names Catherine Owen Adams as new CEO
Premium
The Fly
Acadia Pharmaceuticals names Catherine Owen Adams as new CEO
2M ago
Stoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
Premium
Market News
Stoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
2M ago
Acadia Pharmaceuticals price target lowered to $23 from $26 at Guggenheim
PremiumThe FlyAcadia Pharmaceuticals price target lowered to $23 from $26 at Guggenheim
3M ago
Acadia downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Acadia downgraded to Equal Weight from Overweight at Morgan Stanley
3M ago
Acadia Pharmaceuticals narrows FY24 revenue $930M-$980M, consensus $953.2M
Premium
The Fly
Acadia Pharmaceuticals narrows FY24 revenue $930M-$980M, consensus $953.2M
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100